Docebo
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Mid-pack momentum — held if you own it, not a fresh buy.
- Signal has read HOLD for 4 days.
- Recent price momentum is +33.0% on average (3-month/1-year).
- Main-fund capital flow has been a net inflow over the last 45 sessions.
- Short interest has fallen to 2.1% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 2848 U.S. stocks StockVane covers.
Last computed: 2026-11-22 14:27 UTC
Data coverage: 6 of 6 factors. Missing data is not a zero score.
Valuation C+
How expensive the stock is versus earnings, sales and its own 5-year history.
| P/E (TTM) | 21.2x | Better than 39% |
| Forward P/E | 22.8x | Better than 29% |
| Price / Sales | 3.0x | Better than 42% |
| P/E vs own 5-yr range | 34th pctl | Better than 74% |
Growth A+
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | 19.3% | Better than 81% |
| Net income CAGR (3Y) | 74.8% | Better than 93% |
| Free cash flow CAGR (3Y) | 182.4% | Better than 98% |
Profitability A
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 80.3% | Better than 91% |
| Operating margin | 10.1% | Better than 52% |
| Net margin | 15.5% | Better than 72% |
| Return on equity | 56.9% | Better than 95% |
| Return on invested capital | 53.3% | Better than 99% |
Momentum A+
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | 21.7% | Better than 97% |
| 6-month return | 72.7% | Better than 98% |
| 12-month return (ex latest month) | 46.3% | Better than 81% |
| Distance below 52-week high | 10.5% | Better than 82% |
Financial Health B+
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 1.2x | Better than 30% |
| Debt to assets | 1.2% | Better than 91% |
| Interest coverage | 168.4x | Better than 95% |
| Free cash flow / net income | 72.5% | Better than 23% |
Analyst View B+
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 100.0% | Better than 77% |
| Upside to average target | 27.4% | Better than 45% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.
Performance
Key statistics
Price & volume
- Prev close
- 29.39
- Open
- 29.20
- Day range
- 27.72 - 29.82
- Avg price
- 28.67
- Volume
- 70.03K
- Turnover
- 2.01M
- Turnover ratei
- 0.80%
- Volume ratioi
- 0.75
- Amplitudei
- 7.15%
- 52-week rangei
- 13.32 - 31.08
Valuation
- P/Ei
- 21.73
- P/E (TTM)i
- 21.24
- P/Bi
- -122.02
- EPSi
- 1.28
- Book value / shi
- -0.23
- Net profit
- 31.97M
- Net assets
- -5.69M
Share structure
- Market cap
- 694.84M
- Float capi
- 243.59M
- Shares out
- 24.98M
- Float sharesi
- 8.76M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- --
10.5% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
+1.96M net over the window
Short interest
- Shares short
- 518.51K
- % of floati
- 2.08%
- Days to coveri
- 10.18
- As of
- 2026-10-30
Frequently asked questions
What is the current stock price of Docebo (DCBO)?
Docebo last traded at 27.82. This page shows a periodic quote snapshot. Check the displayed quote time.
What is Docebo's market cap?
About 694.84M.
What is the P/E ratio of Docebo?
The trailing twelve-month P/E is 21.24, below its own 5-year average of 133.54 — in the middle of its historical range (33.52% percentile). See the Valuation tab for the full history.
Does Docebo pay a dividend?
Docebo does not currently pay a regular dividend.
Is Docebo a buy according to analysts?
The consensus of 3 analysts is a Buy rating, with an average 12-month price target of 35.44, which implies 27.4% upside from the current price. This is not investment advice.
What is Docebo's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Docebo a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Docebo discussion 0 comments